Results 131 to 140 of about 1,474,310 (169)
Some of the next articles are maybe not open access.
Respiratory Medicine, 1993
An 18-year-old woman presented initially in 1980 with mild shortness of breath and a chest X-ray showing right lower lobe collapse. Bronchoscopy at this time showed narrowing of the orifice to the lower lobe with a normal mucosal appearance. She was then lost to follow-up until 1988 when she re-presented with a cough productive of purulent sputum and ...
M A, Rider, D, Snead
openaire +2 more sources
An 18-year-old woman presented initially in 1980 with mild shortness of breath and a chest X-ray showing right lower lobe collapse. Bronchoscopy at this time showed narrowing of the orifice to the lower lobe with a normal mucosal appearance. She was then lost to follow-up until 1988 when she re-presented with a cough productive of purulent sputum and ...
M A, Rider, D, Snead
openaire +2 more sources
Current Treatment Options in Oncology, 2001
Plasma cell leukemia (PCL) is a rare aggressive variant of multiple myeloma (MM) characterized by a fulminant course and poor prognosis. The median survival is measured in months. Therapy and prognosis partially depend on whether the disease presents de novo or as a secondary process involving the leukemic transformation of a previously diagnosed MM ...
S R, Hayman, R, Fonseca
openaire +2 more sources
Plasma cell leukemia (PCL) is a rare aggressive variant of multiple myeloma (MM) characterized by a fulminant course and poor prognosis. The median survival is measured in months. Therapy and prognosis partially depend on whether the disease presents de novo or as a secondary process involving the leukemic transformation of a previously diagnosed MM ...
S R, Hayman, R, Fonseca
openaire +2 more sources
Hematology/Oncology Clinics of North America, 2009
Plasma cell myeloma is a heterogenous disease with variable clinical presentation and outcome. The prognosis is largely determined by tumor biology. Newer therapeutic agents are rapidly changing the survival outlook of myeloma patients.
openaire +2 more sources
Plasma cell myeloma is a heterogenous disease with variable clinical presentation and outcome. The prognosis is largely determined by tumor biology. Newer therapeutic agents are rapidly changing the survival outlook of myeloma patients.
openaire +2 more sources
British Journal of Oral and Maxillofacial Surgery, 2008
Plasma cell cheilitis is a rare, idiopathic mucosal condition, which has previously been given scant attention among oral and maxillofacial publications. We present a case of plasma cell cheilitis, with the differential diagnosis and options for treatment.
J N, Farrier, C S, Perkins
openaire +2 more sources
Plasma cell cheilitis is a rare, idiopathic mucosal condition, which has previously been given scant attention among oral and maxillofacial publications. We present a case of plasma cell cheilitis, with the differential diagnosis and options for treatment.
J N, Farrier, C S, Perkins
openaire +2 more sources
New England Journal of Medicine, 1970
PLASMA cells normally secrete immunoglobulins. On occasion, these cells may appear in unusual morphologic forms: grape cells; Mott cells; cells containing Russell bodies; multinuclear cells; thesaurocytes, or flaming cells; and cells with nuclear "dimples." Butterworth et al.1 described a patient with "plasma cell leukemia" whose plasma cells ...
N, Abramson, C, von Kapff, A D, Ginsburg
openaire +2 more sources
PLASMA cells normally secrete immunoglobulins. On occasion, these cells may appear in unusual morphologic forms: grape cells; Mott cells; cells containing Russell bodies; multinuclear cells; thesaurocytes, or flaming cells; and cells with nuclear "dimples." Butterworth et al.1 described a patient with "plasma cell leukemia" whose plasma cells ...
N, Abramson, C, von Kapff, A D, Ginsburg
openaire +2 more sources
Annals of Internal Medicine, 1953
Excerpt INTRODUCTION Plasma cell myeloma is a well known disease often associated with obvious clinical and pathologic findings.
openaire +2 more sources
Excerpt INTRODUCTION Plasma cell myeloma is a well known disease often associated with obvious clinical and pathologic findings.
openaire +2 more sources
Journal of the European Academy of Dermatology and Venereology, 2003
ABSTRACTPlasma cell cheilitis is a rare inflammatory disorder of the lip with a characteristic band‐like infiltrate of plasma cells in the upper dermis. Differential diagnosis should consider allergic/irritant contact cheilitis, candidiasis, syphilis, Queyrat's erythroplasia, granulomatous cheilitis, plasmoacanthoma, plasmacytoma, squamous cell ...
N, Rocha +5 more
openaire +2 more sources
ABSTRACTPlasma cell cheilitis is a rare inflammatory disorder of the lip with a characteristic band‐like infiltrate of plasma cells in the upper dermis. Differential diagnosis should consider allergic/irritant contact cheilitis, candidiasis, syphilis, Queyrat's erythroplasia, granulomatous cheilitis, plasmoacanthoma, plasmacytoma, squamous cell ...
N, Rocha +5 more
openaire +2 more sources
Current Opinion in Pharmacology, 2015
B cells can regulate immunity negatively or positively. Identifying the B cell subsets mediating these antagonistic activities, and the molecular mechanisms governing their differentiation, might enable the development of novel approaches to target B cells therapeutically.
openaire +2 more sources
B cells can regulate immunity negatively or positively. Identifying the B cell subsets mediating these antagonistic activities, and the molecular mechanisms governing their differentiation, might enable the development of novel approaches to target B cells therapeutically.
openaire +2 more sources
Best Practice & Research Clinical Haematology, 2005
Multiple myeloma, the second most common haematopoietic cancer, represents a collection of plasma-cell neoplasms that invariably become fatal when self-renewing myeloma cells begin unrestrained proliferation. Myeloma cells are arrested as intermediates in plasma-cell differentiation as a consequence of transformation.
openaire +2 more sources
Multiple myeloma, the second most common haematopoietic cancer, represents a collection of plasma-cell neoplasms that invariably become fatal when self-renewing myeloma cells begin unrestrained proliferation. Myeloma cells are arrested as intermediates in plasma-cell differentiation as a consequence of transformation.
openaire +2 more sources
Primary Care: Clinics in Office Practice, 2016
Plasma cell disorders are benign, premalignant, and malignant conditions characterized by the presence of a monoclonal paraprotein detected in serum or urine. These conditions are biologically, pathologically, and clinically heterogeneous. There have been major advances in the understanding of the biology of these diseases, which are promoting the ...
openaire +2 more sources
Plasma cell disorders are benign, premalignant, and malignant conditions characterized by the presence of a monoclonal paraprotein detected in serum or urine. These conditions are biologically, pathologically, and clinically heterogeneous. There have been major advances in the understanding of the biology of these diseases, which are promoting the ...
openaire +2 more sources